Company Monitoring Page for Acorda-Therapeutics

latest headlines for company on cafepharma

Acorda cautiously steps forward with a drug to spur remyelination in MS
Fierce Biotech
Mon, 02/2/15 - 07:52 am
Tags:
Acorda Therapeutics, MS, multiple sclerosis, remylination, rHIgM22
Biogen Idec's Critical Nerve Repair Drug is Poised for Big News -- Soon
TheStreet.com
Thu, 01/8/15 - 08:05 am
Tags:
Biogen Idec, nerve repair, BIIB033, anti-LINGO-1, GSK, Vertex Pharmaceuticals, Acorda Therapeutics
3 Companies Growing Faster Than MannKind Corporation
Motley Fool
Wed, 12/17/14 - 08:13 am
Tags:
MannKind, Alexion, Akorn, Acorda Therapeutics
Acorda posts 3Q revenue of $106 million, result beats expectations
Yahoo/AP
Thu, 10/30/14 - 12:15 pm
Tags:
Acorda Therapeutics, earnings
Acorda Down on Plumiaz CRL
Yahoo/Zacks.com
Mon, 05/5/14 - 05:05 pm
Tags:
Acorda Therapeutics, Plumiaz, epilepsy
Acorda Therapeutics says FDA rejects epilepsy drug
Yahoo/Reuters
Fri, 05/2/14 - 08:35 am
Tags:
FDA, epilepsy, Acorda Therapeutics, Plumiaz
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
Tags:
earnings, United Therapeutics, Celgene, Regeneron, Biogen Idec, Acorda Therapeutics, Amgen, Gilead Sciences
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
Tags:
JPMHC 2014, GSK, Intercept Pharma, Acorda Therapeutics, Cell Therapeutics, Novartis, Sanofi, Alnylam, Idenix, Alexion, Galena Biopharma, Incyte, Clovis Oncology, Dendreon, Merck, Arena Pharmaceuticals
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
Tags:
M&A, biotech, generics, Merck, Bristol-Myers Squibb, General Electric, Gilead Sciences, Thermo Fisher, Forest Labs, FDA, Acorda Therapeutics, Pfizer, JNJ, Roche, Pharmacyclics
Acorda Down on Q3 Earnings
Yahoo/Zacks
Mon, 11/4/13 - 09:59 am
Tags:
earnings, Acorda Therapeutics
Acorda: A Biotech Company To Consider
Seeking Alpha
Sat, 04/13/13 - 11:41 am
Tags:
Acorda Therapeutics
Acorda Therapeutics Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Wed, 02/13/13 - 11:02 am
Tags:
Acorda Therapeutics, earnings
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Tags:
Regeneron, Biogen Idec, Acorda Therapeutics, Sanofi, Celgene, Alexion, Biomarin, NPS Pharmaceuticals, Cerner, EXACT Sciences, Pfizer, Bristol-Myers Squibb, Eli Lilly
Potentially game changing data awaits Acorda in 2013
Reuters
Fri, 12/21/12 - 10:42 am
Tags:
Acorda Therapeutics, AMPYRA, stroke
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tue, 09/4/12 - 11:08 am
Tags:
Neurocrine Biosciences, Acorda Therapeutics, Amarin, Nektar
Acorda Therapeutics posts 2nd-quarter profit as sales and royalties from MS drug rise
Yahoo/AP
Tue, 07/31/12 - 01:26 pm
Tags:
earnings, Acorda Therapeutics
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
Tags:
Teva Pharmaceuticals, patents, Mylan, Momenta, Natco, Acorda Therapeutics, Copaxone, MS, multiple sclerosis
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 05:18 pm
Tags:
Bacterin, Biomarin, Athersys, Affymax, Acorda Therapeutics, Alexion
Acorda Therapeutics To FDA: What Deadlines?
Pharmalot
Thu, 05/17/12 - 10:23 am
Tags:
FDA, Acorda Therapeutics, adverse events, AMPYRA
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
Tags:
BIO CEO Conference, Pfizer, Indenix, Keryx, Delcath, Oncothyreon, Acorda Therapeutics, Human Genome Sciences, Gilead

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.